Binding protein capture assay
AssigneeDade Behring Inc.
InventorsFrancee Boches, Kathy F. Hilyard, James Monticello, Dennis Smith, Richard Timmons
Life of this patent
Estimating the term…
Abstract
This invention relates to binding protein assays. In particular, this invention relates to binding protein assays for B12 and folate in serum or plasma. More specifically, this invention provides a sequential assay that uses a combination of specific binding proteins, and anti-binding protein antibodies to measure B12 and folate in serum or plasma.
Claims3
A method to determine an amount of vitamin B12 in a fluid sample, the fluid sample comprising at least some of the vitamin B12 bound to endogenous intrinsic factor, the method comprising:
- treating the fluid sample to free any vitamin B12 in the sample from endogenous intrinsic factor and to destroy the endogenous intrinsic factor's binding ability;
- combining the following with an amount of an immobilized primary antibody which specifically binds exogenous intrinsic factor:
- (a) an amount of exogenous intrinsic factor, (b) the treated fluid sample and (c) an amount of labelled vitamin B12 whereby the immobilized primary antibody binds all of the exogenous intrinsic factor, and any vitamin B12 in said sample and labeled vitamin B12 compete for reaction with the exogenous intrinsic factor;
- measuring the amount of labeled vitamin B12 bound to the primary antibody through the exogenous intrinsic factor;
- and using the measurement of the labeled vitamin B12 to determine the amount of vitamin B12 in the fluid sample.
A method to determine an amount of folate in a fluid sample, the fluid sample comprising at least some of the folate bound to endogenous folate binding protein, the method comprising:
- treating the fluid sample to free any folate in the sample from endogenous folate binding protein and to destroy the endogenous folate binding protein's binding ability;
- combining the following with an amount of an immobilized primary antibody which specifically binds folate binding protein:
- (a) an amount of exogenous folate binding protein, (b) the treated fluid sample and an amount of labelled folate whereby the immobilized primary antibody binds all of the exogenous folate binding protein, (c) and any folate in said sample and labeled folate compete for reaction with the exogenous folate binding protein;
- measuring the amount of labeled folate bound to the primary antibody through the exogenous folate binding protein;
- and using the measurement of the labeled folate to determine the amount of folate in the fluid sample.
A method to determine an amount of an analyte in a fluid sample, the fluid sample comprising at least some of the analyte bound to an endogenous specific binding protein, the method comprising:
- treating the fluid sample to free any of said analyte present in the sample from the endogenous specific binding protein and to destroy the endogenous specific binding protein's binding ability;
- combining the following with an amount of an immobilized primary antibody which reacts specifically with exogenous specific binding protein:
- (a) an amount of exogenous specific binding protein, (b) the treated fluid sample and (c) an amount of labelled analyte whereby the immobilized primary antibody binds all of the exogenous specific binding protein, and any of said analyte present in said sample and labeled analyte compete for reaction with the exogenous specific binding protein;
- measuring the amount of labeled analyte bound to the primary antibody through the exogenous specific binding protein;
- and using the measurement of the labeled analyte to determine the amount of analyte in the fluid sample.
Dependencies are inferred from the claim text.